Orforglipron (LY3502970), a novel, oral nonpeptide glucagonlike peptide1 receptor agonist: a Phase 1a, blinded, placebocontrolled, randomized, singleand multipleascendingdose study in healthy participants
What to eat: Shift to smaller, more frequent meals
"The microdosing strategy has some attractive benefits, including helping to mitigate side effects and being able to customize the dose to the minimum efficacious dose for individual patients," says Katie Sorensen , a nurse practitioner specializing in GLP-1 medications who was not involved in Burgess' treatment
Theres a smarter, science-backed way to restore volume and bounce to your skin
Fatigue and energy changes Some people experience fatigue on GLP-1 medications , especially during the first few weeks
The videos rack up millions of views, and the question keeps coming up: Does this actually work